The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2019
Price : $35 *
At a glance
- Drugs Bimatoprost (Primary) ; Timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Acronyms ARTEMIS
- Sponsors Allergan
- 10 Sep 2019 Status changed from active, no longer recruiting to completed.
- 21 Aug 2019 Trial has been completed Austria.
- 16 Aug 2019 Trial has been completed in Czech Republic, according to European Clinical Trials Database record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History